Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Tuo Zhou in
Google Scholar
PubMed
Search for other papers by Xiuping Xuan in
Google Scholar
PubMed
Search for other papers by Qiuli Cao in
Google Scholar
PubMed
Search for other papers by Zuojie Luo in
Google Scholar
PubMed
Search for other papers by Yingfen Qin in
Google Scholar
PubMed
Search for other papers by Qin Ning in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
Search for other papers by Xuemei Xie in
Google Scholar
PubMed
room temperature and then incubated with primary antibodies including LRP6 (1:1000 dilution; Abcam), β-catenin (1:2000 dilution; Abcam), P70S6K (1:2000 dilution; Abcam), IGF-1R (1:500 dilution; Abcam), IR (1:1000 dilution; Cell Signaling Technology
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Mette Marie Baunsgaard in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Sophie Lind Helligsoe in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Louise Tram Henriksen in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Torben Stamm Mikkelsen in
Google Scholar
PubMed
Search for other papers by Michael Callesen in
Google Scholar
PubMed
Search for other papers by Britta Weber in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Henrik Hasle in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
, GHD can be monitored by linear growth. However, assessment of linear growth is of no use when final height has been reached. Furthermore, insulin-like growth factor 1 (IGF-1) has been questioned as a reliable biochemical proxy marker of GHD in CR
Search for other papers by Ursula M M Costa in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by José A S Barreto-Filho in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Francielle T Oliveira in
Google Scholar
PubMed
Search for other papers by Ivina E S Rocha in
Google Scholar
PubMed
Search for other papers by Joselina L M Oliveira in
Google Scholar
PubMed
Search for other papers by Wersley A Silva in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
Introduction Growth hormone (GH) and its principal mediator insulin-like growth factor 1 (IGF1) have important effects not only on the acquisition of normal body size, but also on metabolic and cardiovascular (CV) status (1) . GH and IGF1 have
Search for other papers by Alessandro Ciresi in
Google Scholar
PubMed
Search for other papers by Stefano Radellini in
Google Scholar
PubMed
Search for other papers by Valentina Guarnotta in
Google Scholar
PubMed
Search for other papers by Maria Grazia Mineo in
Google Scholar
PubMed
Search for other papers by Carla Giordano in
Google Scholar
PubMed
one of the most influential regulators of growth hormone (GH) secretion and action, with different mechanisms ( 2 ). Androgens and estrogens exert opposite endocrine-mediated effects on insulin-like growth factor (IGF)-I production and metabolic
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Search for other papers by Sylvain Roumeau in
Google Scholar
PubMed
Search for other papers by Joannice Thevenon in
Google Scholar
PubMed
CHU Clermont-Ferrand, Service de Biostatistiques, Clermont-Ferrand, France
Search for other papers by Lemlih Ouchchane in
Google Scholar
PubMed
CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Salwan Maqdasy in
Google Scholar
PubMed
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Marie Batisse-Lignier in
Google Scholar
PubMed
CHU Clermont-Ferrand, Inserm CIC 1405, Clermont-Ferrand, France
Search for other papers by Christian Duale in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
CHU de Clermont-Ferrand, Service de chirurgie maxillo-faciale, Clermont-Ferrand, France
Search for other papers by Nathalie Pham Dang in
Google Scholar
PubMed
Search for other papers by Philippe Caron in
Google Scholar
PubMed
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Igor Tauveron in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Chirurgie Dentaire, Clermont-Ferrand, France
Search for other papers by Laurent Devoize in
Google Scholar
PubMed
aspects of the oral condition in this pathology have not been properly described. Indeed, the consequences of elevated GH and IGF-1 on gingivae is debated. Some observations describe a gingival enlargement in acromegalic patients ( 8 ), which is known to
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA
Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA
Search for other papers by Elena V Varlamov in
Google Scholar
PubMed
Search for other papers by Dan Alexandru Niculescu in
Google Scholar
PubMed
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA
Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA
Search for other papers by Swechya Banskota in
Google Scholar
PubMed
Search for other papers by Simona Andreea Galoiu in
Google Scholar
PubMed
Search for other papers by Catalina Poiana in
Google Scholar
PubMed
Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, USA
Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA
Search for other papers by Maria Fleseriu in
Google Scholar
PubMed
comorbidities related to the tumor itself (e.g. headache, oculomotor never palsy or hypopituitarism) or to GH and insulin-like growth factor-1 (IGF-1) excess (arthralgia, morphologic changes, or obstructive sleep apnea (OSA), cardiovascular disease, and
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
Introduction Growth hormone (GH) is a significant regulator of growth and metabolism ( 1 ). In the liver, GH stimulates the synthesis and secretion of insulin-like growth factor 1 (IGF-1) ( 2 ). The GH/IGF-1 axis can regulate hepatic glucose
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
Search for other papers by Shenglong Le in
Google Scholar
PubMed
Search for other papers by Leiting Xu in
Google Scholar
PubMed
The Key Laboratory of Systems Biomedicine, Ministry of Education, and Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China
Search for other papers by Moritz Schumann in
Google Scholar
PubMed
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
Search for other papers by Na Wu in
Google Scholar
PubMed
Search for other papers by Timo Törmäkangas in
Google Scholar
PubMed
Search for other papers by Markku Alén in
Google Scholar
PubMed
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
The Key Laboratory of Systems Biomedicine, Ministry of Education, and Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China
Search for other papers by Sulin Cheng in
Google Scholar
PubMed
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
Department of Epidemiology and Biostatistics, Centre for Environment and Health, School of Public Health, Imperial College London, London, UK
Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
Search for other papers by Petri Wiklund in
Google Scholar
PubMed
Fischer Scientific Inc.) and fasting serum insulin was determined by immunofluorescence using the IMMULITE Analyzer (Diagnostic Products Corporation, Los Angeles, USA). Insulin-like growth factor 1 (IGF-1) was assessed using time
Search for other papers by Anna Kistner in
Google Scholar
PubMed
Search for other papers by Mireille Vanpée in
Google Scholar
PubMed
Search for other papers by Kerstin Hall in
Google Scholar
PubMed
are conflicting concerning leptin levels (5, 17, 18, 19) but elevated levels have been observed in prepubertal SGA children with catch-up growth (19) . IGF-binding protein-1 (IGFBP1) modulates the effect of IGF1 at target tissue. IGFBP1 levels are
Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 1141, DHU PROTECT, Paris, France
Search for other papers by Juliane Léger in
Google Scholar
PubMed
Search for other papers by Anne Fjellestad-Paulsen in
Google Scholar
PubMed
Search for other papers by Anne Bargiacchi in
Google Scholar
PubMed
Search for other papers by Catherine Doyen in
Google Scholar
PubMed
Search for other papers by Emmanuel Ecosse in
Google Scholar
PubMed
Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 1141, DHU PROTECT, Paris, France
Search for other papers by Jean-Claude Carel in
Google Scholar
PubMed
Search for other papers by Marie-France Le Heuzey in
Google Scholar
PubMed
involving the growth hormone (GH)-insulin-like growth factor-I (IGF-I) axis, thyroid function, hypercortisolemia, hypogonadotropic hypogonadism and the levels of several adipokines and gut peptides, such as ghrelin and peptide YY ( 2 ). The